About
Transcatheter Perivascular Denervation
Areas of Focus
Categories
Drug Delivery DeviceBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
847
By Phase
PHASE3: 2PHASE2: 1NA: 2
By Status
COMPLETED: 3RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07083765Lead Sponsor
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
PHASE3Recruiting
142 participants
Started: Sep 1, 2025 · Completed: Oct 31, 2027
NCT02910414Lead Sponsor
TARGET BP I Clinical Trial
PHASE3Active, not recruiting
300 participants
Started: Jul 22, 2019 · Completed: May 31, 2026
NCT03503773Lead Sponsor
The TARGET BP OFF-MED Trial
PHASE2Completed
350 participants
Started: Sep 24, 2018 · Completed: Jan 10, 2024
NCT02570113Lead Sponsor
The Peregrine Post-Market Study for the Treatment of Hypertension
NACompleted
45 participants
Started: Nov 30, 2015 · Completed: Jul 31, 2019
NCT02155790Lead Sponsor
The Peregrine Study: A Safety and Performance Study of Renal Denervation
NACompleted
10 participants
Started: Jul 31, 2014 · Completed: Sep 4, 2017
Locations (1)
Headquarters
Wakefield, MA, United States
Map
Loading map...